735 related articles for article (PubMed ID: 31722709)
1. m
Jia R; Chai P; Wang S; Sun B; Xu Y; Yang Y; Ge S; Jia R; Yang YG; Fan X
Mol Cancer; 2019 Nov; 18(1):161. PubMed ID: 31722709
[TBL] [Abstract][Full Text] [Related]
2. Histone lactylation drives oncogenesis by facilitating m
Yu J; Chai P; Xie M; Ge S; Ruan J; Fan X; Jia R
Genome Biol; 2021 Mar; 22(1):85. PubMed ID: 33726814
[TBL] [Abstract][Full Text] [Related]
3. m
He F; Yu J; Yang J; Wang S; Zhuang A; Shi H; Gu X; Xu X; Chai P; Jia R
Mol Ther; 2021 Jun; 29(6):2121-2133. PubMed ID: 33601055
[TBL] [Abstract][Full Text] [Related]
4. RNA m
Luo G; Xu W; Zhao Y; Jin S; Wang S; Liu Q; Chen X; Wang J; Dong F; Hu DN; Reinach PS; Yan D
J Cell Physiol; 2020 Oct; 235(10):7107-7119. PubMed ID: 32017066
[TBL] [Abstract][Full Text] [Related]
5. Targeting histone deacetylase suppresses tumor growth through eliciting METTL14-modified m
Zhuang A; Gu X; Ge T; Wang S; Ge S; Chai P; Jia R; Fan X
Cancer Commun (Lond); 2023 Nov; 43(11):1185-1206. PubMed ID: 37466203
[TBL] [Abstract][Full Text] [Related]
6. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
Liao Y; Han P; Zhang Y; Ni B
Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
[TBL] [Abstract][Full Text] [Related]
7. YTHDF1-enhanced iron metabolism depends on TFRC m
Ye J; Wang Z; Chen X; Jiang X; Dong Z; Hu S; Li W; Liu Y; Liao B; Han W; Shen J; Xiao M
Theranostics; 2020; 10(26):12072-12089. PubMed ID: 33204330
[No Abstract] [Full Text] [Related]
8. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
9. ZNF677 suppresses renal cell carcinoma progression through N6-methyladenosine and transcriptional repression of CDKN3.
Li A; Cao C; Gan Y; Wang X; Wu T; Zhang Q; Liu Y; Yao L; Zhang Q
Clin Transl Med; 2022 Jun; 12(6):e906. PubMed ID: 35678231
[TBL] [Abstract][Full Text] [Related]
10. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
Yang B; Gu A; Wu Y
Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
[TBL] [Abstract][Full Text] [Related]
11. Dynamic m
Yang F; Jin H; Que B; Chao Y; Zhang H; Ying X; Zhou Z; Yuan Z; Su J; Wu B; Zhang W; Qi D; Chen D; Min W; Lin S; Ji W
Oncogene; 2019 Jun; 38(24):4755-4772. PubMed ID: 30796352
[TBL] [Abstract][Full Text] [Related]
12. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
13. METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.
Li HB; Huang G; Tu J; Lv DM; Jin QL; Chen JK; Zou YT; Lee DF; Shen JN; Xie XB
EBioMedicine; 2022 Aug; 82():104142. PubMed ID: 35810559
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Regulation of mRNA m⁶A Modification in Cancer Development.
Luo J; Liu H; Luan S; He C; Li Z
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149601
[No Abstract] [Full Text] [Related]
15. Diverse molecular functions of m
Han SH; Choe J
Exp Mol Med; 2020 May; 52(5):738-749. PubMed ID: 32404927
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine in nonocular and ocular disease.
Wang N; Yao F; Liu D; Jiang H; Xia X; Xiong S
J Cell Physiol; 2022 Mar; 237(3):1686-1710. PubMed ID: 34913163
[TBL] [Abstract][Full Text] [Related]
17. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
18. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation.
Yue Y; Liu J; He C
Genes Dev; 2015 Jul; 29(13):1343-55. PubMed ID: 26159994
[TBL] [Abstract][Full Text] [Related]
19. The role of m
Chen XY; Zhang J; Zhu JS
Mol Cancer; 2019 May; 18(1):103. PubMed ID: 31142332
[TBL] [Abstract][Full Text] [Related]
20. Changes of N6-methyladenosine modulators promote breast cancer progression.
Wu L; Wu D; Ning J; Liu W; Zhang D
BMC Cancer; 2019 Apr; 19(1):326. PubMed ID: 30953473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
